Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer

BACKGROUND: Precision medicine with gene panel testing based on next-generation sequencing for patients with cancer is being used increasingly in clinical practice. HER2, which encodes the human epidermal growth factor receptor 2 (HER2), is a potentially important driver gene. However, therapeutic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Yohei, Sato, Akemi, Nakamura, Hideaki, Kai, Keita, Kitamura, Sho, Nakamura, Tomomi, Kurihara, Yuki, Ikeda, Sadakatsu, Sueoka, Eisaburo, Kimura, Shinya, Sueoka-Aragane, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872313/
https://www.ncbi.nlm.nih.gov/pubmed/36690964
http://dx.doi.org/10.1186/s12885-022-10428-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872313/
https://www.ncbi.nlm.nih.gov/pubmed/36690964
http://dx.doi.org/10.1186/s12885-022-10428-3

Ejemplares similares